{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:29:15Z","timestamp":1786368555232,"version":"build-2736575974"},"reference-count":202,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hyperuricemia (HUA) is a heterogeneous group of metabolic disorders caused by long-term disturbances in purine metabolism. In recent years, although adult HUA and gout have been extensively studied, the understanding of HUA and gout in children and adolescents remains insufficient. Diagnostic criteria for adult HUA are well-established, but no consensus has yet been reached regarding its definition in children and adolescents. This review summarizes the current understanding of pediatric HUA, emphasizing its genetic basis, metabolic mechanisms, and clinical associations. ATP-binding cassette subfamily G member 2 (ABCG2) dysfunction, gene-defined forms of autosomal dominant tubulointerstitial kidney disease (ADTKD), particularly ADTKD-UMOD and ADTKD-REN, and selected purine metabolism disorders contribute to early-onset HUA, gout, nephrolithiasis, and renal involvement. Obesity-related insulin resistance (IR) may promote urate accumulation through pathways linked to oxidative stress, endothelial dysfunction, and inflammasome activation. Persistent elevation of uric acid (UA) has been associated with chronic kidney disease (CKD) progression, elevated blood pressure (BP), and subclinical cardiovascular remodeling. However, many of these mechanistic associations are supported primarily by adult and experimental studies and require further validation in children. We also review non-pharmacological management and indication-based pharmacological treatment strategies for pediatric HUA. These indications include asymptomatic hyperuricemia (AH), pediatric gout, UA nephrolithiasis, inherited purine metabolism disorders, CKD-associated HUA, and tumor lysis syndrome (TLS)-associated acute HUA, with emphasis on pediatric evidence, regulatory approval, off-label use, dosing, monitoring, and safety. In children, asymptomatic serum urate elevation is often the first recognized presentation, whereas nephrolithiasis, gout, renal dysfunction, or acute HUA should prompt evaluation for genetic, metabolic, renal, or treatment-related causes. These findings underscore the need for early identification and personalized intervention in children with HUA to prevent long-term renal and metabolic complications.<\/jats:p>","DOI":"10.3389\/fendo.2026.1841803","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:40:55Z","timestamp":1786365655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric hyperuricemia: genetic basis, metabolic mechanisms, and clinical implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhuan","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Medicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"First Clinical Medical College, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-03951","article-title":"Gout","volume":"178","author":"FitzGerald","year":"2025","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000274","article-title":"Trends and physiology of common serum biochemistries in children aged 0-18 years","volume":"47","author":"Loh","year":"2015","journal-title":"Pathol (Phila)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-021-00615-3","article-title":"Association of childhood anthropometric measurements and laboratory parameters with high blood pressure in young adults","volume":"44","author":"Azegami","year":"2021","journal-title":"Hypertens Res Off J Jpn Soc Hypertens"},{"key":"B4","unstructured":"Uric Acid, Serum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.semarthrit.2020.04.007","article-title":"The biology of urate","volume":"50","author":"Keenan","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4078\/jrd.2024.0054","article-title":"The pathogenesis of gout","volume":"32","author":"Ahn","year":"2025","journal-title":"J Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2491","article-title":"Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: A mechanism for uric acid-induced endothelial dysfunction","volume":"37","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209632","article-title":"GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes","volume":"76","author":"Nakayama","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13075-019-1860-8","article-title":"The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients","volume":"21","author":"Stiburkova","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/srep02014","article-title":"Common dysfunctional variants in ABCG2 are a major cause of early-onset gout","volume":"3","author":"Matsuo","year":"2013","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex295","article-title":"Functional non-synonymous variants of ABCG2 and gout risk","volume":"56","author":"Stiburkova","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of Febuxostat as a new strong ABCG2 inhibitor: Potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.02.022","article-title":"Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease","volume":"98","author":"Huynh","year":"2020","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.32008","article-title":"Autosomal dominant tubulointerstitial kidney disease: A review","volume":"190","author":"\u017divn\u00e1","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.05.028","article-title":"Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia","volume":"99","author":"Bolar","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105884","article-title":"Genetic background of selected hyperuricemia causing gout with pediatric onset","volume":"92","author":"Stiburkova","year":"2025","journal-title":"Joint Bone Spine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05118-4","article-title":"Autosomal dominant tubulointerstitial kidney disease: more than just HNF1\u03b2","volume":"37","author":"Bleyer","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.06.029","article-title":"Genetic and clinical predictors of age of ESKD in individuals with autosomal dominant tubulointerstitial kidney disease due to UMOD mutations","volume":"5","author":"Kidd","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B24","unstructured":"Autosomal dominant tubulointerstitial kidney disease \u2013 REN\n          \n          \n            \n              \u017divn\u00e1\n              M\n            \n            \n              Kidd\n              K\n            \n            \n              Kmoch\n              S\n            \n            \n              Bleyer\n              AJ\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.041","article-title":"An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes","volume":"98","author":"\u017divn\u00e1","year":"2020","journal-title":"Kidney Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06380613","article-title":"Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1","volume":"9","author":"Bleyer","year":"2014","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B27","unstructured":"Autosomal dominant tubulointerstitial kidney disease \u2013 MUC1\n          \n          \n            \n              Bleyer\n              AJ\n            \n            \n              \u017divn\u00e1\n              M\n            \n            \n              Kidd\n              K\n            \n            \n              Kmoch\n              S\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.72","article-title":"Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin","volume":"86","author":"Ekici","year":"2014","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-025-02629-4","article-title":"Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort","volume":"29","author":"Tanaka","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2024.08.002","article-title":"Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene","volume":"44","author":"Gon\u00e7alves","year":"2024","journal-title":"Nefrol Engl Ed"},{"key":"B31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome","volume":"2","author":"Torres","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15863","article-title":"Age and gender-specific reference intervals for uric acid level and hyperuricemia in children with Down syndrome","volume":"67","author":"Kitoh","year":"2025","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/s41598-021-83379-7","article-title":"One-carbon pathway and cognitive skills in children with Down syndrome","volume":"11","author":"Antonaros","year":"2021","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S448638","article-title":"A gender-, age-, and weight status-specific analysis of the high prevalence of hyperuricemia among Chinese children and adolescents with obesity","volume":"17","author":"Liu","year":"2024","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-00810-9","article-title":"Temporal relationship between body mass index and uric acid and their joint impact on blood pressure in children and adults: the Bogalusa Heart Study","volume":"45","author":"Yun","year":"2021","journal-title":"Int J Obes 2005"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27074","article-title":"Associations between obesity and hyperuricemia combing mendelian randomization with network pharmacology","volume":"10","author":"Panlu","year":"2024","journal-title":"Heliyon"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.792234","article-title":"Skeletal muscle mass has stronger association with the risk of hyperuricemia than body fat mass in obese children and adolescents","volume":"9","author":"Xie","year":"2022","journal-title":"Front Nutr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12989","article-title":"Uric acid and gamma-glutamyl-transferase in children and adolescents with obesity: Association to anthropometric measures and cardiometabolic risk markers depending on pubertal stage, sex, degree of weight loss and type of patient care: Evaluation of the adiposity patient follow-up registry","volume":"18","author":"Weihrauch-Bl\u00fcher","year":"2023","journal-title":"Pediatr Obes"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.8.3362","article-title":"Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity","volume":"89","author":"Terada","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.485094","article-title":"Uric acid secretion from adipose tissue and its increase in obesity","volume":"288","author":"Tsushima","year":"2013","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0911","article-title":"Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation","volume":"56","author":"Hosogai","year":"2007","journal-title":"Diabetes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90760.2008","article-title":"Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue","volume":"296","author":"Yin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1995.268.1.E1","article-title":"Effect of insulin on uric acid excretion in humans","volume":"268","author":"Qui\u00f1ones Galvan","year":"1995","journal-title":"Am J Physiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00012.2017","article-title":"Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2","volume":"313","author":"Toyoki","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3305\/nh.2009.24.5.4491","article-title":"Uric acid is associated with features of insulin resistance syndrome in obese children at prepubertal stage","volume":"24","author":"Gil-Campos","year":"2009","journal-title":"Nutr Hosp"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2020.10.007","article-title":"Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity","volume":"31","author":"Di Bonito","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpped.2015.03.009","article-title":"The role of uric acid in the insulin resistance in children and adolescents with obesity","volume":"33","author":"de Miranda","year":"2015","journal-title":"Rev Paul Pediatr Orgao Soc Pediatr Sao Paulo"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17072277","article-title":"Serum uric acid level as a harbinger of type 2 diabetes: a prospective observation in Taiwan","volume":"17","author":"Wu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04716-y","article-title":"Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease","volume":"36","author":"Karava","year":"2021","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.773820","article-title":"Obesity-induced insulin resistance is mediated by high uric acid in obese children and adolescents","volume":"12","author":"Niu","year":"2021","journal-title":"Front Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2080","article-title":"Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis","volume":"99","author":"Newbern","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0704","article-title":"Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic \u03b2-cell death in uricase-deficient male mice","volume":"69","author":"Lu","year":"2020","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-021-02606-2","article-title":"Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection","volume":"474","author":"Bahadoran","year":"2022","journal-title":"Pflugers Arch"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J Hepatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0916","article-title":"Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome","volume":"60","author":"Baldwin","year":"2011","journal-title":"Diabetes"},{"key":"B60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2021.11.034","article-title":"Silencing TXNIP ameliorates high uric acid-induced insulin resistance via the IRS2\/AKT and Nrf2\/HO-1 pathways in macrophages","volume":"178","author":"Yu","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/jrms.JRMS_733_19","article-title":"Association of serum uric acid concentration with components of pediatric metabolic syndrome: a systematic review and meta-analysis","volume":"25","author":"Goli","year":"2020","journal-title":"J Res Med Sci Off J Isfahan Univ Med Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.6065\/apem.1938156.078","article-title":"Serum uric acid in Korean children and adolescents: reference percentiles and association with metabolic syndrome","volume":"25","author":"Cho","year":"2020","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/nu9030230","article-title":"Fructose and NAFLD: the multifaceted aspects of fructose metabolism","volume":"9","author":"Jegatheesan","year":"2017","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.238","article-title":"Oral fructose absorption in obese children with non-alcoholic fatty liver disease","volume":"10","author":"Sullivan","year":"2015","journal-title":"Pediatr Obes"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3559","article-title":"Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight\/obesity","volume":"38","author":"Di Bonito","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12887-021-02595-2","article-title":"Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity","volume":"21","author":"Peng","year":"2021","journal-title":"BMC Pediatr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13661","article-title":"Liver zonation in children with non-alcoholic fatty liver disease: associations with dietary fructose and uric acid concentrations","volume":"38","author":"Nobili","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000003919","article-title":"Updates in metabolic dysfunction-associated fatty liver disease (MAFLD) in children","volume":"77","author":"Rupasinghe","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2020.1848417","article-title":"Serum uric acid and blood pressure among adolescents: data from the Nutrition and Health Survey in Taiwan (NAHSIT) 2010-2011","volume":"30","author":"Lin","year":"2021","journal-title":"Blood Press"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.10.007","article-title":"Uric acid mediated the relationship between obesity and hypertension in children and adolescents: a population-based cohort study","volume":"34","author":"Rao","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-024-06540-0","article-title":"The association of obesity and hyperuricemia with ambulatory blood pressure in children","volume":"40","author":"Taner","year":"2025","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/children9010006","article-title":"Hyperuricemia and associated factors in children with chronic kidney disease: a cross-sectional study","volume":"9","author":"Xu","year":"2021","journal-title":"Child Basel Switz"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertens Dallas Tex 1979"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-0335-3","article-title":"Association of circulating uric acid and angiotensin-(1-7) in relation to higher blood pressure in adolescents and the influence of preterm birth","volume":"34","author":"South","year":"2020","journal-title":"J Hum Hypertens"},{"key":"B79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s0272-6386(85)80146-3","article-title":"The adolescent with essential hypertension","volume":"6","author":"Gruskin","year":"1985","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"B80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.026","article-title":"Hyperuricemia induces hypertension through activation of renal epithelial sodium channel (ENaC)","volume":"65","author":"Xu","year":"2016","journal-title":"Metabolism"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254590","article-title":"Association between serum uric acid and cardiovascular disease risk factors in adolescents in America: 2001-2018","volume":"16","author":"Shi","year":"2021","journal-title":"PloS One"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.20960\/nh.04343","article-title":"Correlation of uric acid with carotid intima media thickness in obese adolescents","volume":"40","author":"Serret-Montoya","year":"2023","journal-title":"Nutr Hosp"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV22043","article-title":"Gout, uric acid, and coronary artery disease","volume":"32","author":"Nakahashi","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9304383","article-title":"High level of uric acid promotes atherosclerosis by targeting NRF2\u2010mediated autophagy dysfunction and ferroptosis","volume":"21","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.978366","article-title":"Uric acid and arterial stiffness in children and adolescents: role of insulin resistance and blood pressure","volume":"9","author":"Genovesi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.06.015","article-title":"Hyperuricemia and progression of CKD in children and adolescents: the Chronic Kidney Disease in Children (CKiD) Cohort Study","volume":"66","author":"Rodenbach","year":"2015","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05620-3","article-title":"Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents","volume":"38","author":"Schwartz","year":"2023","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402831R","article-title":"Uric acid promotes aortic valve calcification via mediating valve interstitial cell osteogenic differentiation and endothelial dysfunction","volume":"39","author":"Zhang","year":"2025","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin\u2013angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J Hypertens"},{"key":"B91","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/10799893.2021.1931320","article-title":"Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death","volume":"42","author":"Do\u011fru","year":"2022","journal-title":"J Recept Signal Transduct"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress\u2014relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1504328","article-title":"Uric acid reduces the expression of aquaporins in renal collecting ducts to increase urine output in hyperuricemia","volume":"16","author":"Cui","year":"2025","journal-title":"Front Physiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/IJNRD.S549209","article-title":"Mitochondrial oxidative stress and vascular remodeling in uric acid nephropathy: mechanistic insights and therapeutic implications","volume":"18","author":"Liang","year":"2025","journal-title":"Int J Nephrol Renov Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.advms.2023.01.004","article-title":"Urinary levels of kidney injury molecule-1 (KIM-1) and interleukin-18 (IL-18) in children and adolescents with hyperuricemia","volume":"68","author":"Kamianowska","year":"2023","journal-title":"Adv Med Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-023-02538-w","article-title":"Hyperuricemia is associated with the progression of IgA nephropathy in children","volume":"94","author":"Xu","year":"2023","journal-title":"Pediatr Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01379-1","article-title":"Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype","volume":"47","author":"Di Sessa","year":"2023","journal-title":"Int J Obes 2005"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70378","article-title":"Clinical practice consensus statement 2025: management of hyperuricemia and gout in adolescents","volume":"28","author":"Li","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.814166","article-title":"Uric acid is elevated in children with obesity and decreases after weight loss","volume":"9","author":"J\u00f8rgensen","year":"2021","journal-title":"Front Pediatr"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/nu14051034","article-title":"Impact of lifestyle modifications on alterations in lipid and glycemic profiles and uric acid values in a pediatric population","volume":"14","author":"Giussani","year":"2022","journal-title":"Nutrients"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06852","article-title":"Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk","volume":"67","author":"Viazzi","year":"2016","journal-title":"Hypertens Dallas Tex 1979"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1186\/s12889-022-14357-5","article-title":"Association between nutrient patterns and hyperuricemia: mediation analysis involving obesity indicators in the NHANES","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Public Health"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa424","article-title":"Effects of dietary macronutrients on serum urate: results from the OmniHeart trial","volume":"113","author":"Belanger","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173525","article-title":"Gout and diet: a comprehensive review of mechanisms and management","volume":"14","author":"Zhang","year":"2022","journal-title":"Nutrients"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103012","article-title":"Associations of dietary choline intake and kidney function with hyperuricemia in Chinese children and adolescents: a cross-sectional study","volume":"79","author":"Li","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2012.36","article-title":"Dietary fructose in relation to blood pressure and serum uric acid in adolescent boys and girls","volume":"27","author":"Bobridge","year":"2013","journal-title":"J Hum Hypertens"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.01.015","article-title":"Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents","volume":"154","author":"Nguyen","year":"2009","journal-title":"J Pediatr"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-024-03511-x","article-title":"Caffeine intake and cardiometabolic risk factors in adolescents in the United States","volume":"97","author":"Sturm","year":"2025","journal-title":"Pediatr Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102904","article-title":"Longitudinal association of serum 25-hydroxyvitamin D levels with metabolically healthy body size transition in children and adolescents: a prospective cohort study with 2 years of follow-up","volume":"17","author":"Xiao","year":"2023","journal-title":"Diabetes Metab Syndr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/nu16101492","article-title":"The inverted U-shaped association between serum vitamin D and serum uric acid status in children and adolescents: a large cross-sectional and longitudinal analysis","volume":"16","author":"Ma","year":"2024","journal-title":"Nutrients"},{"key":"B111","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0031-3955(16)36876-6","article-title":"Uric acid metabolism in children","volume":"37","author":"Baldree","year":"1990","journal-title":"Pediatr Clin North Am"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3945\/jn.112.160416","article-title":"Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys","volume":"142","author":"Beydoun","year":"2012","journal-title":"J Nutr"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030610","article-title":"Associations between serum vitamin A and metabolic risk factors among Eastern Chinese children and adolescents","volume":"14","author":"Tian","year":"2022","journal-title":"Nutrients"},{"key":"B114","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/1756-185X.12010","article-title":"The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions","volume":"15","author":"Torralba","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.194602","article-title":"Effect of vitamin C supplementation on lipid profile, serum uric acid, and ascorbic acid in children on hemodialysis","volume":"27","author":"El Mashad","year":"2016","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02233","article-title":"Alterations of the gut microbiome associated with the treatment of hyperuricaemia in male rats","volume":"9","author":"Yu","year":"2018","journal-title":"Front Microbiol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2021.1874287","article-title":"The gut microbiota as a target to control hyperuricemia pathogenesis: potential mechanisms and therapeutic strategies","volume":"62","author":"Wang","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845684","article-title":"The role of the intestine in the development of hyperuricemia","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.848715","article-title":"Altered gut microbiota in children with hyperuricemia","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70238","article-title":"Exploring the impact of PA and sedentary behavior on gout risk in hyperuricemia: insights from machine learning and SHAP analysis","volume":"28","author":"Jiao","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.orcp.2021.03.012","article-title":"The relationship between anthropometric factors and hyperuricemia in adolescent athletes","volume":"15","author":"Kuo","year":"2021","journal-title":"Obes Res Clin Pract"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.19538\/j.nk2023060106","article-title":"Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases (2023 edition) [in Chinese","volume":"43","author":"Fang","year":"2023","journal-title":"Chin J Pract Intern Med"},{"key":"B124","article-title":"Essence of the revised guideline for the management of hyperuricemia and gout","volume":"55","author":"Yamanaka","year":"2012","journal-title":"JMAJ"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2015-0290","article-title":"Urate crystals deposition in the feet of overweight juveniles and those with symptomatic hyperuricemia: a dual-energy CT study","volume":"29","author":"Sun","year":"2016","journal-title":"J Pediatr Endocrinol Metab JPEM"},{"key":"B126","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12887-020-02379-0","article-title":"Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database","volume":"20","author":"Ito","year":"2020","journal-title":"BMC Pediatr"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152405","article-title":"Clinical characteristics of adolescent-onset gout in Chinese: a hospital-based cross-sectional study","volume":"65","author":"Li","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"B128","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/annrheumdis-2021-221762","article-title":"Clinical characteristics of juvenile gout and treatment response to febuxostat","volume":"81","author":"Zheng","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-018-0442-8","article-title":"Oral prednisolone versus non-steroidal anti-inflammatory drugs in the treatment of acute gout: a meta-analysis of randomized controlled trials","volume":"26","author":"Yu","year":"2018","journal-title":"Inflammopharmacology"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01042-z","article-title":"Treatment of systemic juvenile idiopathic arthritis","volume":"19","author":"Hinze","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12887-021-03051-x","article-title":"Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database","volume":"21","author":"Honda","year":"2021","journal-title":"BMC Pediatr"},{"key":"B133","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","article-title":"Kidney stones","volume":"2","author":"Khan","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.05.009","article-title":"Urolithiasis in children: medical approach","volume":"59","author":"Copelovitch","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v4.i4.444","article-title":"Pediatric primary urolithiasis: symptoms, medical management and prevention strategies","volume":"4","author":"Penido","year":"2015","journal-title":"World J Nephrol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2011.09.008","article-title":"Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study","volume":"8","author":"Mokhless","year":"2012","journal-title":"J Pediatr Urol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1983.165","article-title":"Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts","volume":"24","author":"Sakhaee","year":"1983","journal-title":"Kidney Int"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.04.108","article-title":"Evaluation and medical management of kidney stones in children","volume":"192","author":"Tasian","year":"2014","journal-title":"J Urol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.775250","article-title":"Kidney stones: an update on current pharmacological management and future directions","volume":"14","author":"Xu","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-014-9731-6","article-title":"Inborn errors of purine metabolism: clinical update and therapies","volume":"37","author":"Balasubramaniam","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2022.02.007","article-title":"Inborn errors of purine and pyrimidine metabolism: a guide to diagnosis","volume":"136","author":"Jurecka","year":"2022","journal-title":"Mol Genet Metab"},{"key":"B142","unstructured":"HPRT1 disorders\n          \n          \n            \n              Jinnah\n              HA\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2007.04.013","article-title":"Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency","volume":"56","author":"Torres","year":"2007","journal-title":"Metabolism"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1159\/000449296","article-title":"Lesch-Nyhan syndrome: models, theories, and therapies","volume":"7","author":"Bell","year":"2016","journal-title":"Mol Syndromol"},{"key":"B145","unstructured":"Phosphoribosylpyrophosphate synthetase superactivity\n          \n          \n            \n              de Brouwer\n              AP\n            \n            \n              Christodoulou\n              J\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02320312","article-title":"Adenine phosphoribosyltransferase deficiency","volume":"7","author":"Boll\u00e9e","year":"2012","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-026-07187-9","article-title":"Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadeninuria","author":"Edvardsson","year":"2026","journal-title":"Pediatr Nephrol"},{"key":"B148","unstructured":"Adenine phosphoribosyltransferase deficiency\n          \n          \n            \n              Edvardsson\n              VO\n            \n            \n              Sahota\n              A\n            \n            \n              Palsson\n              R\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B149","unstructured":"Glycogen storage disease type I\n          \n          \n            \n              Bali\n              DS\n            \n            \n              El-Gharbawy\n              A\n            \n            \n              Austin\n              S\n            \n            \n              Pendyal\n              S\n            \n            \n              Kishnani\n              PS\n            \n          \n          Seattle (WA\n          University of Washington, Seattle\n          Genereviews\u00ae\n          \n          1993"},{"key":"B150","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101021","article-title":"Effectiveness of allopurinol on uric acid and pediatric chronic kidney disease severity in the chronic kidney disease in children study","volume":"7","author":"Ng","year":"2025","journal-title":"Kidney Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3943-1","article-title":"Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease","volume":"33","author":"Ghane Sharbaf","year":"2018","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.11.001","article-title":"An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome","volume":"36","author":"Mughal","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with Malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-013-0009-0","article-title":"Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension","volume":"27","author":"Assadi","year":"2014","journal-title":"J Nephrol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105796","article-title":"Pediatrics hyperuricemia in clinical practice: a retrospective analysis in 1753 children and adolescents with hyperuricemia","volume":"92","author":"Stiburkova","year":"2025","journal-title":"Joint Bone Spine"},{"key":"B158","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/mr\/roae056","article-title":"Efficacy and safety of febuxostat in Japanese paediatric patients with hyperuricaemia including gout: phase 2, single arm, open\u2013label, multicentre studies","volume":"35","author":"Ito","year":"2024","journal-title":"Mod Rheumatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12028","article-title":"Febuxostat as a prophylaxis for tumor lysis syndrome in children with hematological Malignancies","volume":"37","author":"Kishimoto","year":"2017","journal-title":"Anticancer Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10157-023-02394-2","article-title":"Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury","volume":"28","author":"Herrero-Go\u00f1i","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-023-00420-y","article-title":"Safety and effectiveness of rasburicase in the control of hyperuricemia in pediatric patients with non-Hodgkin\u2019s lymphoma and acute leukemia: an open-label, single-arm, multi-center, interventional study","volume":"23","author":"Wang","year":"2023","journal-title":"Drugs RD"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01144-8","article-title":"Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological Malignancies","volume":"42","author":"Pei","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04644-x","article-title":"Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome","volume":"35","author":"Cho","year":"2020","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"B164","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.v97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"B165","unstructured":"ALLOPURINOL injection, powder, lyophilized, for solution"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1177\/1043454214555551","article-title":"Effective prevention and management of tumor lysis syndrome in children with cancer: the important contributions of pediatric oncology nurses","volume":"32","author":"Li","year":"2015","journal-title":"J Pediatr Oncol Nurs Off J Assoc Pediatr Oncol Nurses"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.10.066","article-title":"Radiolucent renal stones in children: combined use of shock wave lithotripsy and dissolution therapy","volume":"73","author":"Mokhless","year":"2009","journal-title":"Urology"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70092","article-title":"British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological Malignancies: a focus on patient safety","volume":"207","author":"Chan","year":"2025","journal-title":"Br J Haematol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.132","article-title":"Allopurinol hypersensitivity: investigating the cause and minimizing the risk","volume":"12","author":"Stamp","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase","volume":"76","author":"Takano","year":"2005","journal-title":"Life Sci"},{"key":"B172","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70032","article-title":"An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction","volume":"12","author":"Iwama","year":"2024","journal-title":"Pharmacol Res Perspect"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12322","article-title":"Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"40","author":"Chou","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100394","article-title":"Febuxostat for treatment of chronic gout","volume":"68","author":"Gray","year":"2011","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"B177","unstructured":"ULORIC (Febuxostat) Tablets, for Oral Use: Prescribing Information"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13290","article-title":"Consensus conference on the management of tumor lysis syndrome","volume":"93","author":"Tosi","year":"2008","journal-title":"Haematologica"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318162bd41","article-title":"SFCE (Soci\u00e9t\u00e9 Fran\u00e7aise de Lutte contre les Cancers et Leuc\u00e9mies de l\u2019Enfant et de l\u2019Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey","volume":"30","author":"Bertrand","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12185-009-0402-6","article-title":"A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic Malignancies at high risk for tumor lysis syndrome","volume":"90","author":"Kikuchi","year":"2009","journal-title":"Int J Hematol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2017.1348415","article-title":"Treatment of tumor lysis syndrome in children with leukemia\/lymphoma in resource-limited settings-efficacy of a fixed low-dose rasburicase","volume":"34","author":"Gopakumar","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"B182","unstructured":"DrugsFDA\n          Rasburicase (Elitek)"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951119001653","article-title":"Rasburicase versus intravenous allopurinol for non-malignancy-associated acute hyperuricemia in paediatric cardiology patients","volume":"29","author":"Moss","year":"2019","journal-title":"Cardiol Young"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27236","article-title":"Comparison of fixed versus traditional weight-based dosing of rasburicase in a pediatric population","volume":"65","author":"Savva","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403566","article-title":"Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of Malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial","volume":"19","author":"Jeha","year":"2005","journal-title":"Leukemia"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006945.pub2","article-title":"Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer","volume":"2010","author":"Cheuk","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.97","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype","volume":"96","author":"Relling","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"B188","unstructured":"Rasburicase\n          \n          LiverTox clin res inf drug-induc liver inj\n          \n          2018"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"J Am Soc Nephrol JASN"},{"key":"B190","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B191","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/s0168-8278(00)80263-9","article-title":"Fatal fulminant hepatic failure associated with benzbromarone","volume":"32","author":"Wagayama","year":"2000","journal-title":"J Hepatol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00176","article-title":"Discovery of Dotinurad (FYU-981), a new phenol derivative with highly potent uric acid lowering activity","volume":"11","author":"Uda","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.259341","article-title":"Pharmacological evaluation of Dotinurad, a selective urate reabsorption inhibitor","volume":"371","author":"Taniguchi","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"B194","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1124\/jpet.124.002096","article-title":"Unique binding sites of uricosuric agent Dotinurad for selective inhibition of renal uric acid reabsorptive transporter URAT1","volume":"390","author":"Fujita","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-017-0461-y","article-title":"Lesinurad: a review in hyperuricaemia of gout","volume":"34","author":"Deeks","year":"2017","journal-title":"Drugs Aging"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key100","article-title":"Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study","volume":"57","author":"Shiramoto","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab198","article-title":"Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study","volume":"60","author":"Lin","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.597370","article-title":"Investigation on hyperuricemia in children with obesity or various pediatric disorders","volume":"30","author":"Kubota","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.06.008","article-title":"Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease","volume":"162","author":"Noone","year":"2013","journal-title":"J Pediatr"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2019.00444","article-title":"Prevalence of hyperuricemia and its association with metabolic syndrome and cardiometabolic risk factors in Korean children and adolescents: analysis based on the 2016-2017 Korea National Health and Nutrition Examination Survey","volume":"62","author":"Lee","year":"2019","journal-title":"Korean J Pediatr"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-01185-9","article-title":"Uric acid reference values: report on 1750 healthy Brazilian children and adolescents","volume":"89","author":"Moulin-Mares","year":"2021","journal-title":"Pediatr Res"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1177\/00099228241238510","article-title":"Serum uric acid levels among Chinese children: reference values and association with overweight\/obesity","volume":"63","author":"Ye","year":"2024","journal-title":"Clin Pediatr (Phila)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1841803\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:41:02Z","timestamp":1786365662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1841803\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":202,"alternative-id":["10.3389\/fendo.2026.1841803"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1841803","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1841803"}}